Clinical Trials Browser

Enrolling by invitation × durvalumab × 1 year × Clear all

NCT05303532 2026-02-23

ROSY-D

Phase 3 Enrolling by invitation

Neoplasms

NCT06419179 2025-05-20

GUIDANCE

Phase 2 Enrolling by invitation

Small Cell Lung Carcinoma